Skip to main content
. 2022 Aug 15;23(16):9168. doi: 10.3390/ijms23169168

Figure 1.

Figure 1

Prognostic biomarkers in patients with acute myocardial infarction. AST, aspartate transaminase; BNP, brain natriuretic peptide; CK-MB, creatine kinase-MB; cysC, cystatin C; CRP, C-reactive protein; Gal-3, galectin-3; GDF-15, growth differentiation factor-15; H-FABP, heart-type fatty acid binding protein; IL-6, interleukin-6; IL-37, interleukin-37; LIPCAR, a long noncoding ribonucleic acid; MicroRNAs, microribonucleic acids; MR-proADM, mid-regional proadrenomedullin; NT-proBNP, N terminal pro-brain natriuretic peptide; PLT, platelet; Sdc-1, syndecan-1; sST2, soluble suppression of tumorigenicity-2; TSP-1, thrombospondin-1.